Status:
COMPLETED
Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis
Lead Sponsor:
Allergan
Conditions:
Hypotrichosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily to the upper eyelid margins (where the eyelashes meet the skin) compared with vehicle in increasing overall ey...
Eligibility Criteria
Inclusion
- African American/ethnic black
- Adults at least 18 years of age
- Eyelash prominence assessment of minimal or moderate
Exclusion
- Subjects with uneven lashes or longer on one side than the other
- Any eye disease or abnormality
- Eye surgery
- Severe hyperpigmentation around the eye
- Eyelash implants
- Eyelash extension application
- Any use of eyelash growth products within 6 months
- Any use of prescription eyelash growth products
- Treatments that may affect hair growth
- Requiring eye drop medications for glaucoma
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT00958035
Start Date
November 1 2009
End Date
August 1 2010
Last Update
January 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philadelphia, Pennsylvania, United States